MedWatch

Leo presents new strategy: doubles research investment

Leo Pharma’s strategy for the next seven years is ready and it involves a massive upgrade of the research in well-known as well as new disease areas. However, this also means decreasing financial results for the company in the years to come.

Foto: POLFOTO: CARSTEN BUNDGAARD

For the next seven years, Leo Pharma’s research and development investments will be significantly upgraded.

It became clear this week as the Danish drug group is planning its 2025 strategy. And even though the company has been stuffing the pipeline by collecting research collaborations, acquisitions and licenses for years, the management is still aiming for more.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier